124 related articles for article (PubMed ID: 17362766)
1. FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model.
Kaudel CP; Frink M; van Griensven M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2007 Mar; 39(2):493-8. PubMed ID: 17362766
[TBL] [Abstract][Full Text] [Related]
2. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration.
Kaudel CP; Frink M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; van Griensven M; Winkler M
Transplant Proc; 2007 Mar; 39(2):499-502. PubMed ID: 17362767
[TBL] [Abstract][Full Text] [Related]
3. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice.
Kaudel CP; Schmiddem U; Frink M; Bergmann S; Pape HC; Krettek C; Klempnauer J; Winkler M
Transplant Proc; 2006 Apr; 38(3):679-81. PubMed ID: 16647442
[TBL] [Abstract][Full Text] [Related]
4. FTY720 impairs necrosis development after ischemia-reperfusion injury.
Oliveira CM; Borra RC; Franco M; Schor N; Silva HT; Pestana JO; Bueno V
Transplant Proc; 2004 May; 36(4):854-6. PubMed ID: 15194292
[TBL] [Abstract][Full Text] [Related]
5. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs.
Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M
J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822
[TBL] [Abstract][Full Text] [Related]
6. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
7. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
[TBL] [Abstract][Full Text] [Related]
8. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury.
Suleiman M; Cury PM; Pestana JO; Burdmann EA; Bueno V
Transplant Proc; 2005; 37(1):373-4. PubMed ID: 15808648
[TBL] [Abstract][Full Text] [Related]
9. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
[TBL] [Abstract][Full Text] [Related]
10. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
Wang MH; Milekhin V; Zhang H; Huang HZ
Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
[TBL] [Abstract][Full Text] [Related]
11. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
[TBL] [Abstract][Full Text] [Related]
12. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
Liu L; Wang C; He X; Shang W; Bi Y; Wang D
Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
[TBL] [Abstract][Full Text] [Related]
14. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
Lopes CT; Gallo AP; Palma PV; Cury PM; Bueno V
Transplant Proc; 2008 Apr; 40(3):856-60. PubMed ID: 18455036
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury.
da Silva LB; Palma PV; Cury PM; Bueno V
Int Immunopharmacol; 2007 Dec; 7(13):1609-16. PubMed ID: 17996670
[TBL] [Abstract][Full Text] [Related]
16. FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
Ando S; Amano H; Amano E; Minowa K; Watanabe T; Nakano S; Nakiri Y; Morimoto S; Tokano Y; Lin Q; Hou R; Ohtsuji M; Tsurui H; Hirose S; Takasaki Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):804-10. PubMed ID: 20233577
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.
Czech B; Pfeilschifter W; Mazaheri-Omrani N; Strobel MA; Kahles T; Neumann-Haefelin T; Rami A; Huwiler A; Pfeilschifter J
Biochem Biophys Res Commun; 2009 Nov; 389(2):251-6. PubMed ID: 19720050
[TBL] [Abstract][Full Text] [Related]
18. FTY720: early clinical experience.
Dragun D; Fritsche L; Boehler T; Peters H; Budde K; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):544S-548S. PubMed ID: 15041403
[TBL] [Abstract][Full Text] [Related]
19. The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat.
Popovic J; Kover KL; Moore WV
Pediatr Diabetes; 2004 Mar; 5(1):3-9. PubMed ID: 15043683
[TBL] [Abstract][Full Text] [Related]
20. [Effect of mono and combination therapy with FTY720 and ICAM-1 mAb for mouse-to-rat cardiac xenotransplantation].
Xiong HB; Huang ZF; Ye QF; Xia SS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):41-6. PubMed ID: 17344585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
